Risk factor | Univariate | Multi-variate | ||
---|---|---|---|---|
Odds ratio (95% CI) | P value | Odds ratio (95% CI) | P value | |
Sex | ||||
 Male | 1 | Ref | 1 | Ref |
 Female | 0.64 (0.59–0.68) | <0.001 | 0.65 (0.60–0.71) | <0.001 |
Age category | ||||
 18–30 years | 1 | Ref | 1 | Ref |
 31–50 years | 7.32 (3.76–14.26) | <0.001 | 3.01 (1.51–6.01) | 0.002 |
 Over 50 years | 19.76 (10.11–38.64) | <0.001 | 7.08 (3.53–14.19) | <0.001 |
Baseline ART regimen | ||||
 TDF-3TC-EFV | 1 | Ref | 1 | Ref |
 AZT-3TC-EFV | 1.65 (1.47–1.86) | <0.001 | 1.04 (0.91–1.20) | 0.557 |
 TDF-3TC-NVP | 1.74 (1.51–2.01) | <0.001 | 1.54 (1.31–1.81) | <0.001 |
 AZT-3TC-NVP | 1.92 (1.76–2.09) | <0.001 | 1.64 (1.47–1.83) | <0.001 |
 Other | 1.78 (1.57–2.01) | <0.001 | 1.31 (1.13–1.52) | <0.001 |
Duration of ART | ||||
 <2 years | 1 | Ref | 1 | Ref |
 2 to 5 years | 0.91 (0.82–1.01) | 0.081 | 0.78 (0.70–0.87) | <0.001 |
 5 to 10 years | 1.60 (1.45–1.76) | <0.001 | 0.99 (0.88–1.12) | 0.893 |
 >10 years | 2.70 (2.32–3.13) | <0.001 | 1.56 (1.30–1.87) | <0.001 |